Zogenix

ZGNX NASDAQ
50.01
-1.45
-2.82%
盘后: 50.01 0 0.00% 16:09 08/23 EDT
开盘
51.30
昨收
51.46
最高
52.14
最低
49.57
成交量
42.16万
成交均量(3M)
49.08万
52周最高
56.50
52周最低
33.43
换手率
0.99%
市值
21.28亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Zogenix ZGNX股票价格,Zogenix股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008, is a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. ZX008 has received orphan drug designation in the United States and European Union (EU), for the treatment of Dravet syndrome. The Company has an additional product candidate, Relday (risperidone once-monthly long-acting injectable) for the treatment of schizophrenia. Relday is a long-acting injectable formulation of risperidone. Risperidone is used to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. It has completed the Phase I program for Relday.
展开 >

最近浏览

名称
价格
涨跌幅